Crystal structure of peptide-bound neprilysin reveals key binding interactions
- PMID: 31514225
- DOI: 10.1002/1873-3468.13602
Crystal structure of peptide-bound neprilysin reveals key binding interactions
Abstract
Neprilysin (NEP) is a promiscuous zinc metalloprotease with broad substrate specificity and cleaves a remarkable diversity of substrates through endopeptidase action. Two of these - amyloid-β and natriuretic peptides - implicate the enzyme in both Alzheimer's disease and cardiovascular disease, respectively. Here, we report the creation of a catalytically inactive NEP (E584D) to determine the first peptide-bound crystal structure at 2.6 Å resolution. The structure reveals key interactions involved in substrate binding which we have identified to be conserved in other known zinc metalloproteases. In addition, the structure provides evidence for a potential exosite within the central cavity that may play a critical role in substrate positioning. Together, these results contribute to our understanding of the molecular function of NEP.
Keywords: NEP; crystallography; neprilysin; neutral endopeptidase; peptide-bound; protein structure; zinc metalloprotease.
© 2019 Federation of European Biochemical Societies.
References
-
- Erdös EG and Skidgel RA (1989) Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J 3, 145-151.
-
- Rawlings ND, Barrett AJ, Thomas PD, Huang X, Bateman A and Finn RD (2018) The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database. Nucleic Acids Res 46, D624-D632.
-
- Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, Gerard C, Hama E, Lee HJ and Saido TC (2001) Metabolic regulation of brain Aβ by neprilysin. Science 292, 1550-1552.
-
- Bayes-Genis A, Barallat J and Richards AM (2016) A test in context: neprilysin: function, inhibition, and biomarker. J Am Coll Cardiol 68, 639-653.
-
- Von Lueder TG, Sangaralingham SJ, Wang BH, Kompa AR, Atar D, Burnett JC and Krum H (2013) Renin-Angiotensin blockade combined with natriuretic peptide system augmentation. Circ Hear Fail 6, 594-605.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
